Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
GSK
Biotech
Wave reports AATD win, but investors lukewarm
The biotech's stock slipped even though its RNA editing treatment restored alpha-1 antitrypsin to clinically meaningful levels.
Darren Incorvaia
Sep 3, 2025 3:00pm
Big Pharma-backed program seeks future beyond animal testing
Aug 1, 2025 5:00pm
GSK anti-TIM-3 antibody flunks ph. 3, as TIGIT fail costs $629M
Jul 30, 2025 5:27am
GSK strengthens COPD offering via $12B biobucks Hengrui deal
Jul 28, 2025 4:36am
GSK plans 'very limited' job cuts for global R&D team
Jul 15, 2025 4:15pm
Sanofi vaccine vet vaults to GSK—Chutes & Ladders
Jun 13, 2025 8:30am
